TADALAFIL

Jubilant Generics received FDA approval for a new tadalafil product (application 210329, supplement 004).

Jubilant Generics' tadalafil product (NDA 210329) received FDA approval.

Jubilant Generics' tadalafil NDA 210329 supplement 002 received approval for a new product formulation or indication.

Jubilant Generics' tadalafil product received FDA approval under ANDA 210329, supplement 003.